This document discusses fertility and infertility, including chances of conception, factors that affect fertility, evaluating fertility, and treatment options. It provides information on:
1. The chances of conception within 1 year of unprotected intercourse is 80% and within 1.5 years is 90%. Investigations should be waited after 1 year of trying.
2. Factors that can affect fertility include lifestyle factors like smoking, alcohol, obesity, occupational heat exposure, and recreational drug use. Medical conditions and medications can also impact fertility.
3. Evaluating fertility involves testing for issues like abnormal semen analysis, ovulation disorders, tubal damage, uterine anomalies, and assessing ovarian reserve. Treatment depends on identified causes and may include lifestyle
This document provides an overview of infertility, including its definition, types, incidence, risk factors, diagnosis, treatment, and the role of midwives. It defines infertility as the inability to conceive after one year of unprotected sex. Various female and male factors that can cause infertility are described. Diagnostic tests for both men and women are outlined. Treatment options include lifestyle changes, fertility drugs, surgery, and assisted reproductive technologies like IUI, IVF, and ICSI. The importance of infertility counseling to help couples cope with emotional aspects is also discussed.
Physiology of Menstrual Cycle dr Ahmed Walid Anwar MoradWalid Ahmed
The document summarizes key aspects of the female menstrual cycle, including its regulation by the hypothalamic-pituitary-ovarian axis and the ovarian and uterine cycles. It describes the follicular phase, ovulation, and luteal phase of the ovarian cycle and the proliferative, secretory, and menstrual phases of the uterine cycle. It also discusses cervical mucus changes, dysmenorrhea, premenstrual syndrome, and the hormones involved in regulating the menstrual cycle.
Recent advancement in infertility final pptLalitaSharma39
This document provides an overview of recent advancements in infertility management. It begins with definitions of infertility and its types. It then discusses various causes of female infertility including age, smoking, STIs, weight, chemotherapy, genetic factors, and issues with the fallopian tubes, uterus, cervix, and vagina. Tests for infertility and treatment options like laparoscopy, medication, and assisted reproductive technologies are also outlined. Specific ART procedures described in detail include IUI, IVF, GIFT, ZIFT, ICSI, and ovary transplants.
Evaluation and options in Managing Subfertile CoupleEddie Lim
Subfertility - Failure to conceive within 12 months of
regular sexual intercourse without any form
of contraception.
Woman older than 35 years -- have not
conceived during a 6-month period of trying.
it describes in detail about causes, investigations and management of female infertility.in the end of presentation, it includes a video demonstration to describe the management options of assisted conception.
1. Gestational trophoblastic disease (GTD) is abnormal growth of trophoblast cells that can range from benign to malignant. It includes complete and partial hydatidiform moles, as well as gestational trophoblastic neoplasia (GTN) such as invasive mole, choriocarcinoma, and placental site trophoblastic tumor.
2. A 24-year-old woman presented at 14 weeks pregnant with vaginal bleeding, nausea, vomiting, and elevated blood pressure. On examination, her uterus was enlarged beyond gestational age and no fetal heart tone was detected.
3. GTD is typically diagnosed through ultrasound, urine and blood tests. Molar pregnancies are
This document provides an overview of infertility, including its definition, types, incidence, risk factors, diagnosis, treatment, and the role of midwives. It defines infertility as the inability to conceive after one year of unprotected sex. Various female and male factors that can cause infertility are described. Diagnostic tests for both men and women are outlined. Treatment options include lifestyle changes, fertility drugs, surgery, and assisted reproductive technologies like IUI, IVF, and ICSI. The importance of infertility counseling to help couples cope with emotional aspects is also discussed.
Physiology of Menstrual Cycle dr Ahmed Walid Anwar MoradWalid Ahmed
The document summarizes key aspects of the female menstrual cycle, including its regulation by the hypothalamic-pituitary-ovarian axis and the ovarian and uterine cycles. It describes the follicular phase, ovulation, and luteal phase of the ovarian cycle and the proliferative, secretory, and menstrual phases of the uterine cycle. It also discusses cervical mucus changes, dysmenorrhea, premenstrual syndrome, and the hormones involved in regulating the menstrual cycle.
Recent advancement in infertility final pptLalitaSharma39
This document provides an overview of recent advancements in infertility management. It begins with definitions of infertility and its types. It then discusses various causes of female infertility including age, smoking, STIs, weight, chemotherapy, genetic factors, and issues with the fallopian tubes, uterus, cervix, and vagina. Tests for infertility and treatment options like laparoscopy, medication, and assisted reproductive technologies are also outlined. Specific ART procedures described in detail include IUI, IVF, GIFT, ZIFT, ICSI, and ovary transplants.
Evaluation and options in Managing Subfertile CoupleEddie Lim
Subfertility - Failure to conceive within 12 months of
regular sexual intercourse without any form
of contraception.
Woman older than 35 years -- have not
conceived during a 6-month period of trying.
it describes in detail about causes, investigations and management of female infertility.in the end of presentation, it includes a video demonstration to describe the management options of assisted conception.
1. Gestational trophoblastic disease (GTD) is abnormal growth of trophoblast cells that can range from benign to malignant. It includes complete and partial hydatidiform moles, as well as gestational trophoblastic neoplasia (GTN) such as invasive mole, choriocarcinoma, and placental site trophoblastic tumor.
2. A 24-year-old woman presented at 14 weeks pregnant with vaginal bleeding, nausea, vomiting, and elevated blood pressure. On examination, her uterus was enlarged beyond gestational age and no fetal heart tone was detected.
3. GTD is typically diagnosed through ultrasound, urine and blood tests. Molar pregnancies are
The document discusses infertility, defining it as the inability to conceive after one year of unprotected intercourse. It notes that infertility affects 10-15% of couples and discusses the main causes, which include female factors in 50% of cases, male factors in 35% of cases, and unexplained causes in 10-15% of cases. The major sections of the document cover ovulation disorders, tubal and peritoneal factors, uterine factors, cervical factors, and male factors in infertility.
This document discusses infertility, including its definition, causes, diagnostic evaluation, and management. It notes that infertility is defined as the inability to conceive after one year of unprotected intercourse. The causes of infertility can be male factors related to sperm production or transport, female factors related to ovulation or egg/hormone problems, or combined factors in both partners. Diagnostic evaluation involves medical histories, physical exams, sperm analysis, hormone testing, imaging of reproductive organs, and other tests to identify treatable causes. Management depends on the underlying causes and may include lifestyle changes, surgery, assisted reproductive technologies like IVF, or alternatives to childbirth like adoption.
This document discusses infertility, including definitions, incidence, and causes. It provides details on evaluating male and female infertility. For males, investigations include semen analysis and hormone testing. For females, ovulation is evaluated through basal body temperature charts, cervical mucus tests, hormone levels, and endometrial biopsies to check for anovulation, luteal phase defects, or tubal/uterine issues. Treatment options of medical management and surgery are also mentioned.
This document provides an outline on infertility, including definitions, incidence, classifications, factors responsible for fertility, etiology, investigation, and management. It notes that infertility affects 10-15% of couples in developed countries and 25-30% in Nigeria. Causes are classified as male factors (40%), female factors (40%), combined (10%), or unexplained (5-10%). Investigations include semen analysis, ovulation confirmation, and tubal patency tests. Management includes treating any etiological factors, ovulation induction drugs, surgery, and artificial reproductive techniques like IVF and ICSI.
Infertility and endometriosis 01.04.2021Shazia Iqbal
This document discusses infertility, its causes in men and women, endometriosis, and treatment options. Infertility is defined as not being able to get pregnant after one year of unprotected sex. It can be caused by problems in men or women. Male factors include abnormal sperm or hormone issues, while female factors include ovulation disorders, damaged fallopian tubes, or endometriosis. Endometriosis involves endometrial tissue growing outside the uterus, causing pain, and increasing infertility risk. Treatments include lifestyle changes, medications, surgery, and assisted reproduction.
The document defines primary and secondary infertility and describes their causes and evaluation. It states that infertility affects 15% of couples and can be caused by problems with ovulation, sperm production or the female reproductive tract. Diagnostic tests include semen analysis, tests of ovulation and HSG. Treatment depends on the underlying cause but may include fertility drugs to induce ovulation, surgery to repair reproductive organs or assisted reproduction techniques like IUI or IVF. The prognosis is best for anovulatory infertility which can often be treated with ovulation induction.
A 33-year-old Omani woman presented with severe lower abdominal pain for 3 days after undergoing ICSI (intra-cytoplasmic sperm injection) treatment for primary infertility. She has a history of infertility for 6 years, including a failed IUI (intrauterine insemination) treatment 2 years ago. A physical exam and medical history were taken. The woman has been experiencing primary infertility for 6 years despite various fertility treatments.
This document provides guidelines on the evaluation and treatment of infertility. It discusses causes of infertility such as ovulatory disorders, tubal factors, male factors, and unexplained infertility. For evaluation, it recommends assessments of ovulation and tubal patency through tests such as progesterone levels, ultrasound, hysterosalpingogram, and laparoscopy. It provides treatment guidelines for ovulation induction with clomiphene citrate or gonadotropins, tubal surgery, and assisted reproductive technologies including IUI and IVF for male factor infertility. Lifestyle changes like weight loss and stopping smoking are also recommended.
This document provides information on infertility, including its definition, causes, risk factors, diagnosis and investigations, and management options. It defines infertility as not conceiving after one year of unprotected sex. The most common causes are male factors (30%), ovulatory disorders (25%), and tubal damage (20%). Risk factors include advanced age, smoking, alcohol, weight factors, and certain infections or exposures. Diagnosis involves medical history, physical exams, and tests like semen analysis, ovulation assessments, and imaging. Treatment may include lifestyle changes, medications, surgery, and assisted reproductive technologies like IUI, IVF, and ICSI.
This document provides guidelines for the management of infertility. It discusses investigations such as semen analysis and tubal patency testing. It covers the diagnosis and management of issues like PCOS, male factor infertility, tubal disease, ovulation disorders, and endometriosis. The guidelines are based on evidence from meta-analyses, randomized controlled trials, and protocols from organizations like RCOG and ASRM. Both medical and surgical treatment options are considered.
Female and male infertility Causes & Management by Asar KhanAsar Khan
In this Presentation we have included the male and female infertility their causes and Management. we hope that it will provide you some basic information regarding this issues.
This document outlines an action plan for the prevention, detection, and management of infertility. It discusses the need for such a plan given infertility is a growing public health issue. The plan aims to improve access to diagnosis and treatment through primary, secondary, and tertiary prevention approaches. It also seeks to establish low-cost in vitro fertilization to help more people address infertility issues. Key factors that influence infertility treatment costs and outcomes are identified. Prevention strategies target conditions like sexually transmitted infections that can lead to tubal damage. The role of lifestyle factors in both causing and treating infertility is addressed. Diagnostic tools and assisted reproduction techniques are outlined along with when each is most appropriate. Challenges in making these services accessible in developing countries are
medical management of infertility,think before surgery!!!!ShitalSavaliya1
Nowdays infertility is major issues world wide,It covers both male and female infertility causes,investigation and related treatments.it also includes recent options available at infertility centres.
Infertility: Causes (Men, Women), Symptoms, Diagnosis and TreatmentYashodaHospitals
Find out about the challenges of infertility, when to see a doctor, causes, symptoms, diagnosis and treatments including insemination and in vitro fertilization.
This document discusses ectopic pregnancy, which occurs when a fertilized egg implants outside the uterus, most commonly in a fallopian tube. It presents a significant health risk and is a leading cause of maternal death in early pregnancy. While the incidence of ectopic pregnancy has increased in recent decades, improved diagnosis and treatment have reduced mortality rates by 80%. Key aspects of managing ectopic pregnancy discussed include using transvaginal ultrasound, beta-hCG levels, and laparoscopy to detect high-risk cases early. Treatment options presented are expectant management, medical management using methotrexate, and surgical management via laparoscopy or laparotomy.
This document discusses infertility, including its definition, causes, evaluation, and treatment options. It begins by defining primary and secondary infertility and outlining the requirements for conception. Common causes of infertility for both men and women are then described. The document provides details on evaluating infertility, including medical history, physical exams, lab tests, and procedures like semen analysis and hysterosalpingography. Treatment options are covered, such as ovulation induction, surgery, assisted reproductive technologies like IUI, IVF, and surrogacy. The emotional impact of infertility is also addressed.
The document discusses infertility, its causes and treatments. It defines infertility as the inability to conceive after one year of regular unprotected sex. Approximately 10-15% of couples experience infertility, with female factors accounting for 60% of cases, male factors 30% and both male and female factors in 10% of cases. Common female causes include problems with ovulation, fallopian tubes or cervical factors. Common male causes include abnormal sperm production or function. Treatments aim to address the specific cause, and may include ovulation induction medications, surgery, assisted reproduction technologies like IUI or IVF.
The document discusses infertility, defining it as the inability to conceive after one year of unprotected intercourse. It notes that infertility affects 10-15% of couples and discusses the main causes, which include female factors in 50% of cases, male factors in 35% of cases, and unexplained causes in 10-15% of cases. The major sections of the document cover ovulation disorders, tubal and peritoneal factors, uterine factors, cervical factors, and male factors in infertility.
This document discusses infertility, including its definition, causes, diagnostic evaluation, and management. It notes that infertility is defined as the inability to conceive after one year of unprotected intercourse. The causes of infertility can be male factors related to sperm production or transport, female factors related to ovulation or egg/hormone problems, or combined factors in both partners. Diagnostic evaluation involves medical histories, physical exams, sperm analysis, hormone testing, imaging of reproductive organs, and other tests to identify treatable causes. Management depends on the underlying causes and may include lifestyle changes, surgery, assisted reproductive technologies like IVF, or alternatives to childbirth like adoption.
This document discusses infertility, including definitions, incidence, and causes. It provides details on evaluating male and female infertility. For males, investigations include semen analysis and hormone testing. For females, ovulation is evaluated through basal body temperature charts, cervical mucus tests, hormone levels, and endometrial biopsies to check for anovulation, luteal phase defects, or tubal/uterine issues. Treatment options of medical management and surgery are also mentioned.
This document provides an outline on infertility, including definitions, incidence, classifications, factors responsible for fertility, etiology, investigation, and management. It notes that infertility affects 10-15% of couples in developed countries and 25-30% in Nigeria. Causes are classified as male factors (40%), female factors (40%), combined (10%), or unexplained (5-10%). Investigations include semen analysis, ovulation confirmation, and tubal patency tests. Management includes treating any etiological factors, ovulation induction drugs, surgery, and artificial reproductive techniques like IVF and ICSI.
Infertility and endometriosis 01.04.2021Shazia Iqbal
This document discusses infertility, its causes in men and women, endometriosis, and treatment options. Infertility is defined as not being able to get pregnant after one year of unprotected sex. It can be caused by problems in men or women. Male factors include abnormal sperm or hormone issues, while female factors include ovulation disorders, damaged fallopian tubes, or endometriosis. Endometriosis involves endometrial tissue growing outside the uterus, causing pain, and increasing infertility risk. Treatments include lifestyle changes, medications, surgery, and assisted reproduction.
The document defines primary and secondary infertility and describes their causes and evaluation. It states that infertility affects 15% of couples and can be caused by problems with ovulation, sperm production or the female reproductive tract. Diagnostic tests include semen analysis, tests of ovulation and HSG. Treatment depends on the underlying cause but may include fertility drugs to induce ovulation, surgery to repair reproductive organs or assisted reproduction techniques like IUI or IVF. The prognosis is best for anovulatory infertility which can often be treated with ovulation induction.
A 33-year-old Omani woman presented with severe lower abdominal pain for 3 days after undergoing ICSI (intra-cytoplasmic sperm injection) treatment for primary infertility. She has a history of infertility for 6 years, including a failed IUI (intrauterine insemination) treatment 2 years ago. A physical exam and medical history were taken. The woman has been experiencing primary infertility for 6 years despite various fertility treatments.
This document provides guidelines on the evaluation and treatment of infertility. It discusses causes of infertility such as ovulatory disorders, tubal factors, male factors, and unexplained infertility. For evaluation, it recommends assessments of ovulation and tubal patency through tests such as progesterone levels, ultrasound, hysterosalpingogram, and laparoscopy. It provides treatment guidelines for ovulation induction with clomiphene citrate or gonadotropins, tubal surgery, and assisted reproductive technologies including IUI and IVF for male factor infertility. Lifestyle changes like weight loss and stopping smoking are also recommended.
This document provides information on infertility, including its definition, causes, risk factors, diagnosis and investigations, and management options. It defines infertility as not conceiving after one year of unprotected sex. The most common causes are male factors (30%), ovulatory disorders (25%), and tubal damage (20%). Risk factors include advanced age, smoking, alcohol, weight factors, and certain infections or exposures. Diagnosis involves medical history, physical exams, and tests like semen analysis, ovulation assessments, and imaging. Treatment may include lifestyle changes, medications, surgery, and assisted reproductive technologies like IUI, IVF, and ICSI.
This document provides guidelines for the management of infertility. It discusses investigations such as semen analysis and tubal patency testing. It covers the diagnosis and management of issues like PCOS, male factor infertility, tubal disease, ovulation disorders, and endometriosis. The guidelines are based on evidence from meta-analyses, randomized controlled trials, and protocols from organizations like RCOG and ASRM. Both medical and surgical treatment options are considered.
Female and male infertility Causes & Management by Asar KhanAsar Khan
In this Presentation we have included the male and female infertility their causes and Management. we hope that it will provide you some basic information regarding this issues.
This document outlines an action plan for the prevention, detection, and management of infertility. It discusses the need for such a plan given infertility is a growing public health issue. The plan aims to improve access to diagnosis and treatment through primary, secondary, and tertiary prevention approaches. It also seeks to establish low-cost in vitro fertilization to help more people address infertility issues. Key factors that influence infertility treatment costs and outcomes are identified. Prevention strategies target conditions like sexually transmitted infections that can lead to tubal damage. The role of lifestyle factors in both causing and treating infertility is addressed. Diagnostic tools and assisted reproduction techniques are outlined along with when each is most appropriate. Challenges in making these services accessible in developing countries are
medical management of infertility,think before surgery!!!!ShitalSavaliya1
Nowdays infertility is major issues world wide,It covers both male and female infertility causes,investigation and related treatments.it also includes recent options available at infertility centres.
Infertility: Causes (Men, Women), Symptoms, Diagnosis and TreatmentYashodaHospitals
Find out about the challenges of infertility, when to see a doctor, causes, symptoms, diagnosis and treatments including insemination and in vitro fertilization.
This document discusses ectopic pregnancy, which occurs when a fertilized egg implants outside the uterus, most commonly in a fallopian tube. It presents a significant health risk and is a leading cause of maternal death in early pregnancy. While the incidence of ectopic pregnancy has increased in recent decades, improved diagnosis and treatment have reduced mortality rates by 80%. Key aspects of managing ectopic pregnancy discussed include using transvaginal ultrasound, beta-hCG levels, and laparoscopy to detect high-risk cases early. Treatment options presented are expectant management, medical management using methotrexate, and surgical management via laparoscopy or laparotomy.
This document discusses infertility, including its definition, causes, evaluation, and treatment options. It begins by defining primary and secondary infertility and outlining the requirements for conception. Common causes of infertility for both men and women are then described. The document provides details on evaluating infertility, including medical history, physical exams, lab tests, and procedures like semen analysis and hysterosalpingography. Treatment options are covered, such as ovulation induction, surgery, assisted reproductive technologies like IUI, IVF, and surrogacy. The emotional impact of infertility is also addressed.
The document discusses infertility, its causes and treatments. It defines infertility as the inability to conceive after one year of regular unprotected sex. Approximately 10-15% of couples experience infertility, with female factors accounting for 60% of cases, male factors 30% and both male and female factors in 10% of cases. Common female causes include problems with ovulation, fallopian tubes or cervical factors. Common male causes include abnormal sperm production or function. Treatments aim to address the specific cause, and may include ovulation induction medications, surgery, assisted reproduction technologies like IUI or IVF.
This document discusses subfertility, which is defined as the failure to conceive within 1 year of unprotected regular sexual intercourse. It describes various factors that can affect fertility in both men and women, including ovulation disorders, tubal damage, age, sexually transmitted diseases, endometriosis, and male factors like varicocele and low semen quality. The management of subfertility involves taking a history, examination, and investigations to determine the cause, followed by treatments tailored to the specific diagnosis, such as clomiphene citrate for ovulation disorders or surgery for tubal disease.
This document provides information about infertility, including definitions, causes, tests, and treatments. It notes that infertility is defined as failure to conceive within one year of unprotected sex. The most common causes are issues with ovulation (30% of cases), male factor infertility (30%), and tubal damage or blockages (30-50% of female cases). Diagnostic testing involves assessing hormone levels, semen analysis, hysterosalpingography, and laparoscopy. Treatment depends on the underlying cause but may include fertility drugs, artificial insemination, in vitro fertilization (IVF), or surgery. Success rates vary based in the cause but range from 20-60% for treatments and 15-43% for IV
The patient is a 29-year-old woman who has been trying to get pregnant for 1.5 years without success. Her history shows irregular periods, weight gain, acne, and facial hair. Examination found she has an android body type and signs of polycystic ovary syndrome. Initial tests should include checking ovulation with basal body temperature and ovulation predictor kits, semen analysis for her partner, and laboratory tests. Further evaluation in three months could include a hysterosalpingogram to check the fallopian tubes if still not pregnant.
This document discusses polycystic ovarian disease (PCOD) and its homoeopathic approach. It provides an overview of normal ovarian anatomy and the female reproductive cycle. PCOD is characterized by ovarian dysfunction, hyperandrogenism, and polycystic ovaries. It affects 6-8% of women and is more prevalent in obese women. The causes are thought to involve genetic and environmental factors as well as metabolic disorders like insulin resistance. Homoeopathic remedies that may be useful for treating PCOD symptoms and ovarian cysts include Apis, Bufo, Carb-an, Graphites, Iodum, Kali-brom, Lachanesis, Lycopodium, Merc-c, and Plat
Infertility is defined as the inability to conceive after one year of unprotected intercourse. It can be caused by issues with ovulation, the fallopian tubes, uterus, cervix, or vagina in women or by low sperm count or quality, obstruction, or ejaculation issues in men. Diagnostic evaluation involves medical histories, physical exams, and lab tests of both partners. Treatment may include medications to stimulate ovulation, artificial insemination, in vitro fertilization, gamete intrafallopian transfer, or zygote intrafallopian transfer depending on the causes of infertility.
This document discusses infertility, including its causes, investigations, and management. It notes that 5-10% of normal couples take over a year to conceive. Common causes of infertility include sperm defects, ovulation failure, tubal damage, and unexplained infertility. Investigations involve semen analysis, progesterone testing, and hormone levels. Treatment depends on the cause, such as IVF for sperm issues, clomifene or metformin for ovulation disorders, and antibiotics and referral for tubal damage. Referral is advised for older women, long-term infertility, positive chlamydia tests, or abnormal hormone or semen analysis results.
This document discusses various factors that can cause infertility in males and females. It describes abnormalities that can impair sperm production or function in males such as low sperm count, abnormal sperm morphology or motility. It also discusses erection or ejaculation issues. In females, it mentions disorders of ovulation, fallopian tube abnormalities, cervical issues, or recurrent pregnancy loss as factors. Some diagnostic tests and treatments for infertility are also outlined such as semen analysis, ovulation predictor kits, fertility drugs, artificial insemination, IVF etc.
This document discusses infertility in both males and females. It defines primary and secondary infertility and lists various factors that can cause infertility in males and females. For males, it discusses abnormalities of sperm, erection, ejaculation and seminal fluid. For females, it discusses disorders of ovulation, fallopian tubes, cervix and recurrent pregnancy loss. It also discusses diagnostic tests and treatments for infertility including fertility drugs, assisted reproductive technologies like IVF, and surrogacy.
1. Infertility is defined as the failure to conceive within one year of regular unprotected intercourse or six months if the woman is over 35.
2. Common causes of infertility include problems with ovulation, blocked fallopian tubes, age, previous tubal ligation, endometriosis, low sperm count, blocked sperm passage, or sperm that do not function properly.
3. Treatment options for women include fertility drugs to stimulate ovulation, while options for men include treatments for impotence, infections, or too few sperm. Assisted reproductive technologies include intrauterine insemination, in vitro fertilization, zygote intrafallopian transfer, and intracytoplasmic sperm injection.
Infertility can be caused by female or male factors and is defined as the inability to conceive after one year of regular unprotected sex. Common causes include problems with ovulation, the fallopian tubes, sperm quality, or other issues. Treatment may include fertility drugs to stimulate ovulation, surgery to repair damaged reproductive organs, artificial insemination (IUI), in vitro fertilization (IVF), or other assisted reproductive technologies (ART) like GIFT or ZIFT. The goal of treatment is to address the underlying cause of infertility and increase the chances of conception and pregnancy.
Infertility affects approximately 15% of couples globally and can be caused by female or male factors. Evaluating both partners is important to determine the cause, which may include issues with ovulation, fallopian tubes, sperm, or other uterine or hormonal problems. Treatment options range from ovulation-inducing drugs, surgery to repair issues, and assisted reproductive technologies like IVF, IUI, or ICSI depending on the underlying cause.
This document provides information on infertility, including definitions, causes, evaluation, and treatment of male and female factor infertility. It defines infertility as the inability to conceive after one year of unprotected intercourse. Causes of infertility can be due to male factors, female factors, or a combination of both. Evaluation of infertility involves medical history, physical exam, and diagnostic testing such as semen analysis, ovulation testing, and imaging. Treatment depends on the underlying cause but may include lifestyle changes, medication, surgery, artificial insemination, IVF, or adoption.
This document discusses infertility, its causes and treatments including assisted reproductive technologies. It notes that infertility has risen 50% in India over recent decades with 46% of Indians aged 31-40 requiring medical help to conceive. Both male and female factors contribute nearly equally to infertility. After evaluating causes for each couple, treatments may include ovulation induction, intrauterine insemination, in vitro fertilization, intracytoplasmic sperm injection or use of donor gametes. New assisted reproduction techniques have increased options but the best treatment depends on the individual infertility factors involved.
This couple has been trying to conceive for over 2 years without success. The woman has regular periods and examinations are normal. Testing shows she is ovulating regularly with normal hormone levels, making polycystic ovary syndrome unlikely. The man's semen analysis is also normal, ruling out any male factor causes. As both evaluations are normal, lifestyle advice around confirmed rubella immunity, weight, alcohol, and smoking cessation would be the next steps before considering further fertility treatments.
Infertility is defined as the failure to conceive after one year of unprotected intercourse. It can be caused by factors related to the male, female or both partners. Evaluation involves medical history, physical exam, semen analysis, hormone tests, imaging and other procedures to determine the cause. Treatment depends on the underlying cause and may include lifestyle changes, medication, surgery or assisted reproductive technologies. The goal is to address any identifiable medical issues and improve the chances of natural or assisted conception.
- Infertility is a problem through out and increasing rates noticed.
- The successful birth of a “Test Tube Baby”, Louise Brown occurred in 1978 in Oldham General Hospital, U.K.
- Roberts G. Edwards; the physiologist who developed the treatment was awarded the noble prize in Medicine in 2010.
Infertility is “a disease of the reproductive system defined by the failure to achieve a clinical pregnancy after 12 months or more of regular unprotected sexual intercourse.”
By World Health Organization
This document discusses menopause and postmenopausal bleeding. It defines menopause as the permanent cessation of menstruation from loss of ovarian activity, which can only be determined after 12 months of amenorrhea. Postmenopausal bleeding occurs in 4-11% of menopausal women and requires evaluation. Causes include atrophic changes, polyps, hormonal therapy, and malignancy such as endometrial cancer. Evaluation involves history, exam, ultrasound, and endometrial biopsy to diagnose and treat any identified issues.
Bleeding in early pregnancy can be due to miscarriage, ectopic pregnancy, or other causes. Signs and symptoms may include vaginal bleeding, abdominal or pelvic pain, and a positive pregnancy test. Evaluation involves assessing the last menstrual period, risk factors, ultrasound findings, and serum hCG levels. Management depends on the diagnosis and clinical situation, and may involve expectant monitoring, medical treatment with misoprostol or methotrexate, or surgical evacuation. The goal is to identify life-threatening ectopic pregnancies while preserving future fertility when possible.
This document provides an overview of urinary incontinence. It begins by outlining the learning objectives, which are to understand normal bladder function, define different types of incontinence, understand their pathophysiology and assessments, and review management options. It then defines continence and incontinence. The main types of incontinence discussed are stress urinary incontinence, urgency urinary incontinence, and overflow incontinence. Risk factors, evaluations including history, exams, and tests are explained. Management options covered include lifestyle changes, pelvic floor exercises, medications, and surgeries like sling procedures.
This document discusses common gastrointestinal disorders in pregnancy, including nausea and vomiting of pregnancy (NVP) and hyperemesis gravidarum (HG). It notes that NVP affects 60-70% of pregnancies and usually resolves by 20 weeks, while HG is a more severe form affecting 0.3-2% of pregnancies, causing significant weight loss and requiring hospitalization. The document explores potential causes of HG including hormones, genetics, and H. pylori infection. It also outlines signs, symptoms, complications, treatment including rehydration and antiemetics, and prognosis of HG.
This document discusses benign uterine tumors, specifically focusing on uterine fibroids (leiomyomas). It describes the incidence, classification, symptoms, investigations, and management options for uterine fibroids. Regarding management, it discusses expectant management, medical management using various drugs, and surgical options including myomectomy and hysterectomy. The goal of management is to individualize treatment based on a patient's symptoms, fibroid characteristics, and reproductive plans.
This document discusses gestational trophoblastic disease (GTD), including classifications, genetics, risk factors, clinical features, investigations, management, and follow up. GTD includes benign, non-neoplastic lesions like molar pregnancies as well as gestational trophoblastic neoplasms. Molar pregnancies are classified as complete or partial moles. Complete moles usually arise from abnormal fertilization, while partial moles are usually triploid. Follow up of molar pregnancies involves monitoring beta-hCG levels to detect persistent trophoblastic disease.
This document provides an overview of the management of normal labour and use of the partogram. It defines normal labour according to WHO and describes the three stages of labour - first stage from onset to full cervical dilation, second stage from full dilation to delivery, and third stage from delivery to delivery of the placenta. It explains the physiology of labour and outlines the assessment, monitoring, and management of each stage of labour. It also provides detailed instructions on how to complete and interpret the partogram to monitor labour progress and detect abnormalities.
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxwalterHu5
In some case, your chronic prostatitis may be related to over-masturbation. Generally, natural medicine Diuretic and Anti-inflammatory Pill can help mee get a cure.
Osteoporosis - Definition , Evaluation and Management .pdfJim Jacob Roy
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
Travel vaccination in Manchester offers comprehensive immunization services for individuals planning international trips. Expert healthcare providers administer vaccines tailored to your destination, ensuring you stay protected against various diseases. Conveniently located clinics and flexible appointment options make it easy to get the necessary shots before your journey. Stay healthy and travel with confidence by getting vaccinated in Manchester. Visit us: www.nxhealthcare.co.uk
Kosmoderma Academy, a leading institution in the field of dermatology and aesthetics, offers comprehensive courses in cosmetology and trichology. Our specialized courses on PRP (Hair), DR+Growth Factor, GFC, and Qr678 are designed to equip practitioners with advanced skills and knowledge to excel in hair restoration and growth treatments.
5-hydroxytryptamine or 5-HT or Serotonin is a neurotransmitter that serves a range of roles in the human body. It is sometimes referred to as the happy chemical since it promotes overall well-being and happiness.
It is mostly found in the brain, intestines, and blood platelets.
5-HT is utilised to transport messages between nerve cells, is known to be involved in smooth muscle contraction, and adds to overall well-being and pleasure, among other benefits. 5-HT regulates the body's sleep-wake cycles and internal clock by acting as a precursor to melatonin.
It is hypothesised to regulate hunger, emotions, motor, cognitive, and autonomic processes.
Travel Clinic Cardiff: Health Advice for International TravelersNX Healthcare
Travel Clinic Cardiff offers comprehensive travel health services, including vaccinations, travel advice, and preventive care for international travelers. Our expert team ensures you are well-prepared and protected for your journey, providing personalized consultations tailored to your destination. Conveniently located in Cardiff, we help you travel with confidence and peace of mind. Visit us: www.nxhealthcare.co.uk
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
2. Chances of conception
Unprotected intercourse for 1 year – 80%
Unprotected intercourse for 1.5 years –
90%
Wait for one year before investigating
3. Erection
Penetration
Ejaculation & deposit in the right place
No cervical hostility
Normal uterus
Normal fallopian tubes
Normal ovulation
4.
5. After ovulation, the egg usually lives for up to
24 hours. After ejaculation, sperm can survive
for up to seven days in the genital tract and
some times even longer.
The decline with age in rates of conception is
seen after age 30 years of age and is more
marked after 35 years.
The effect of age on male fertility is less
clear.
6. The best sperm motility has been found in
semen emission every three to four days on
average.
Coitus every two to three days is likely to
maximise the overall chance of natural
conception, as spermatozoa survive in the
female reproductive tract for up to seven
days after insemination.
The highest estimated conception rates
associated with intercourse two days before
ovulation.
7. Depends on cycle length
1 14 28
1 21 35
- 18 Short cycle to -10 Long cycle
1 10 25
8. Alcohol
Excessive alcohol consumption can be
detrimental to the semen quality but the
effect is reversible and there is no evidence of
causal association between moderate alcohol
consumption and poor semen quality.
9. There is a significant association between
smoking and reduced fertility among female
smokers.
There is an association in men between
smoking and reduced semen parameters.
10. Women with BMI over 30 kg/m
2
take longer
to conceive, compared with women with
lower BMI
There is reduced number of normal motile
sperm cells in men who are overweight (BMI
25 – 30) and obese (BMI greater than 30)
when compared with men of normal weight
(BMI 20 – 24).
Obesity may have a deleterious effect on
erectile function of men with existing
vascular risk
11. Important determinants of testicular
temperature such as a sedentary work
position and occupational heat exposure have
been associated with abnormal semen
quality.
12. Prescribed drug use
Nonsteroidal anti-inflammatory drugs
inhibit ovulation.
Immunosuppressive and ant-inflammatory
drugs for rheumatic disease may affect
conception.
In a case-control study, women who had
ever used thyroid replacement hormones,
antidepressants, tranquilizers or asthma
medication were reported to have elevated
risks of anovulatory infertility.
13. Recreational drugs
The use of recreational drugs or drugs abuse
such as marijuana and cocaine can adversely
affect ovulatory and tubal function.
The use of drugs such as anabolic steroids
and cocaine can adversely affect semen
quality.
17. Tubal disease
Endosalpingitis leading to obstruction
Pelvic adhesions – distorting tubal anatomy
Uterine factors
Uterine anomalies
Endometrial disease
18. Ovulatory disorders
WHO classification of ovulatory disorders
a. Hypothalamic pituitary failure (10%)
b. Hypothalamic pituitary dysfunction
(85%) - PCOD
c. Ovarian failure (4%)
19.
20.
21. Problems of Delivery
Ejaculatory dysfunction Erectile dysfunctions
Obstruction
Problems of Production
Count Motility Morphology Volume
22.
23. Finding Cause
Abnormal count
Azoospermia Klinefelter's syndrome or other genetic disorders
Sertoli-cell-only syndrome
Seminiferous tubule or Leydig cell failure
Hypogonadotrophic hypogonadism
Ductal obstruction, including Young's syndrome
Varicocele
Exogenous factors
Oligozoospermia Genetic disorder
Endocrinopathies, including androgen receptor defects
Varicocele and other anatomic disorders
Maturation arrest
Hypospermatogenesis
Exogenous factors – Alcohol,Smoking
Abnormal volume
No ejaculate Ductal obstruction
Retrograde ejaculation
Ejaculatory failure
Hypogonadism
Low volume Obstruction of ejaculatory ducts
Absence of seminal vesicles and vas deferens
Partial retrograde ejaculation
Infection
High volume Unknown factors
Abnormal motility Immunologic factors
Infection
Varicocele
Defects in sperm structure
Metabolic or anatomic abnormalities of sperm
Poor liquefaction of semen
Abnormal viscosity Etiology unknown
Abnormal morphology Varicocele
Stress
Infection
Exogenous factors
Causes of
Semen
Abnormalities
• The characteristics
of semen may vary
over time and
undergo normal
biological variability,
if an abnormality is
found, it is best to
repeat the test on
two or three
occasions.
24. Age over 35 years
Previous pelvic surgery
History of endometriosis
History of PID
Disorders of ovulation
Abnormal sperm parameters
25. Investigation of the male
Seminal Fluid Analysis
Seminal Fluid Culture/ABST
Investigation of the female
Hormonal Assay
Tubal Patency assessment
Assessment of pelvic pathology
26. This is a sensitive test (sensitivity of 89%), but
has poor specificity.
Analysis of repeat semen samples provides
greater specificity in identifying semen
abnormalities; a single-sample analysis will
falsely identify about 10% of men as
abnormal.
But repeating the test reduces this to 2%.
Always Repeat
27. Volume ≥ 2.0ml
pH ≥ 7.2
Sperm concentration ≥20x106 spermatozoa/ml
Total sperm number ≥ 40x106 spermatozoa
per ejaculation
Motility ≥ 50% motile
or
≥ 25% with progressive
motility (grade a)
within 60 minutes of
ejaculation
Morphology ≥ 30% of normal morphology
Vitality ≥50% live
White blood cells <1x106 per ml
28.
29. Assessing ovarian reserve
An elevated basal D3 FSH is correlated with
diminished ovarian reserve and associated
with poor pregnancy rates after ovulation
induction.
Antral Folllicle count
Anti mullerian factor
30. a. Hypothalamic pituitary failure (10%)
b. Hypothalamic pituitary dysfunction
(85%)
c. Ovarian failure (4%)
31. Assessing ovulation
Regular menstrual cycles - 26 to 36 days
cycles are usually indicative of ovulation.
In practice, testing for release of the oocyte by
observing follicle rupture is impractical
Serum Progesterone
ovulation detection is based on the detection
of circulating progesterone produced
following leutinisation of the follicle.
(measurement of serum progesterone in mid
luteal phase, approximately on day 21st of a
28 day cycle.)
32. For women with irregular cycles this test may
need to be performed later in the cycle (e.g.
day 28 of a 35 day cycle) and repeated weekly
until the next menstrual cycle starts.
33. Prolactin Measurement
Estimation of prolactin level should be
reserved for women with symptoms of an
ovulatory disorder , galactorrhoea or a
pituitary tumour.
Assessment of Thyroid Function
34.
35. Diagnosis of the PCOS requires the presence of
at least two of the following three criteria.
1. Oligo- and/or anovulation
2. Clinical and/or biochemical
hyperandrogenism
3. Polycystic ovaries, with the
exclusion of other aetiologies.
36. The new definition for the diagnosis of a
polycystic ovary (which is usually obtained
from an ultrasound scan) requires the
presence of at least 12 follicles measuring 2-
9 mm in diameter and/or an ovarian volume
in excess of 10 cm3
.
Polycystic ovaries are present in about 80-
90% of women with oligomenorrhoea and
30% of women with amenorrhoea.
37.
38. Luteal phase defect is estimated to affect 3-
20% of the infertile population and 23-60% of
women with current miscarriage.
The benefit of treatment for luteal-phase
defect on pregnancy rates has not been
established.
39. systematic review of 11 observational studies
showed that the postcoital has poor
predictive power of fertility and lacks validity.
47. Primary Level
Educate - Stop smoking
alcohol
occupation
Educate - Fertile period
Coital frequency
Coital problems
Seminal Fluid analysis
48. Secondary level
Induction of ovulation
◦ Clomiphene citrate
◦ Clomiphene Citrate+ Gonadotrophins
◦ Metformin is used in patients with evidence of
insulin resistance
49. Multiple pregnancy rates were seen in
those women who conceived following
laparoscopic drilling
53. Male factor infertility
Tubal disease
Endometriosis
Unexplained fertility problems
treatment for cancer where cryopreserved
semen is unsuitable for IUI.
Ovarian failure
requirement for egg donation
54. Male factor infertility
Tubal disease
Endometriosis
Unexplained fertility problems
treatment for cancer where cryopreserved
semen is unsuitable for IUI.
Ovarian failure
requirement for egg donation
55. Pituitary down regulation
Ovarian stimulation
Egg collection followed by semen production
or sperm recovery
IVF/ICSI
Transfer of resulting embryos to the uterus
Luteal support (administration of hormones
to aid implantation of embryos).
76. Obstructive azoospermia
Nonobstructive azoospermia
Infectious disease in the male partner (such
as HIV)
Severe deficits in semen quality in couples
who do not to wish to undergo
intracytoplasmic sperm injection.
Certain cases where there is a high risk of
transmitting a genetic disorder to the
offspring.
77. Premature ovarian failure
Gonadal dysgenesis including Turner
syndrome.
Bilateral oophorectomy
Ovarian failure following chemotherapy or
radiotherapy.
Certain cases of in vitro fertilization treatment
failure.
Oocyte donation should also be considered in
certain cases where there is a high risk of
transmitting a genetic disorder to the
offspring.